A confirmed hantavirus case and five suspected infections aboard the MV Hondius have killed three passengers. The virus almost never spreads between humans — which makes the transmission chain aboard a crowded vessel deeply unsettling.
Until last week, infants weighing under five kilograms had no malaria drug built for them. A new WHO-approved treatment changes that — but getting it to 30 million babies a year is the next challenge.
Purdue Pharma will cease to exist by Friday. The Sackler family will pay up to $7 billion over 15 years. Individual victims can expect $8,000 to $16,000 — if they can find decades-old prescription records.
When information was scarcest, the AI nailed the diagnosis 67% of the time. Two expert physicians managed 50% to 55%. The study used real ER patients, not curated test cases.
Congress appropriated $607.5 million for international family planning this year. The State Department says it's 'still evaluating' — while nearly 1,400 clinics have closed and $9.7 million in contraceptives sit in a Belgian warehouse.
Rising obesity tracks with rising cancer rates in adults under 50 — but explains only a fraction of the increase. The search for what's driving the rest is just beginning.
From this year forward, Britain will bury more people than it welcomes. The ONS says the shift is permanent — and the consequences land hardest on the young.
62% of patients who received a single CRISPR infusion had zero swelling attacks for six months — no ongoing treatment required. It's the first time gene editing inside a living body has cleared a Phase 3 trial.
By 2060, nearly 50 million Chinese citizens could have dementia, with annual costs surpassing $5 trillion. Beijing's new national campaign aims to develop four original drugs — but the last homegrown Alzheimer's treatment was just pulled from the market.
Europe just authorized the world's first combo flu-COVID vaccine. The same shot, developed in Massachusetts, has been stalled at the FDA for over a year.
A 12-amino-acid peptide discovered by an AI algorithm targets the brain's appetite center directly, bypassing the pathways that make GLP-1 drugs cause nausea. Human trials are coming.
Children born deaf are hearing whispers after a single injection. The FDA just approved the first gene therapy to restore a sense — and its maker is providing it free of charge in the US.
Kennedy refused to promise he'd let his own CDC director set vaccine policy without interference. The next day, his agency killed a study showing vaccines cut hospitalizations in half.
For 55 years, the federal government classified marijuana alongside heroin. The Justice Department is now poised to change that — under a Republican president whose own party mostly opposes the move.
A once-daily pill nearly doubled survival in metastatic pancreatic cancer, targeting a mutation considered impossible to drug for 40 years. The data has oncologists using language they normally avoid.
Congenital anomalies have doubled in Gaza since 2022. Stillbirths are up 140 percent. The babies in Nasser Hospital's neonatal ward are the evidence — and doctors say most cannot be treated.
Two proven malaria vaccines. Bed nets. Antimalarial drugs. In 2024, the disease still killed 610,000 people. The missing ingredient is not science.
A phase III trial of an mRNA vaccine against H5N1 bird flu is underway in the UK and US — preparing for a pandemic that may never come, but that virologists consider all but inevitable.
Amazon's One Medical launched a national GLP-1 program with same-day pharmacy delivery. Shares of Hims & Hers, Eli Lilly, and Novo Nordisk all dropped on the news.
Britain has passed a law creating two classes of adults: those who can legally buy cigarettes, and those who never will. New Zealand tried the same approach — and reversed it before it took effect.
lop News
Carl Sage
Maynard Keys